Anti-inflammatory pain-relieving effects of Amanita muscaria

This article is based on a scientific study conducted by a group of scientists from Brazil in 2013 on mice. The aim of the study was to investigate the effect of compounds obtained from the red fly agaric on reducing inflammatory pain.
The scientists focused on two polysaccharides from the red amanita mushroom - fucomanogalactan and β-D-glucan. These substances have shown strong anti-inflammatory properties, which can be useful for the development of new medical drugs.
Fucomanogalactan is a polysaccharide consisting of fucose, mannose and galactose. It is known for its ability to modulate the body's immune response, making it potentially useful in the treatment of inflammatory diseases.
β-D-glucan is another polysaccharide found in the cells of a number of fungi, including the red amanita mushroom. It has immunomodulatory properties and can help improve the immune response.

This research is important for humanity because it opens up new opportunities for the development of more effective and safer drugs for the treatment of inflammatory conditions and pain. In particular, these compounds can become an alternative to traditional painkillers, which often have side effects or limitations in use.
Thus, the results of this study can have a significant impact on the future of medicine, opening new horizons in the understanding and use of natural resources to improve human health.
Data from this study can be used to treat or alleviate a variety of inflammatory diseases and pain conditions. Because fucomanogalactan and β-D-glucan have anti-inflammatory properties, they may be useful in the treatment of autoimmune disorders, inflammatory bowel disease, arthritis, and post-traumatic and chronic pain relief.
The original article and a full translation are available to our regular customers

Our Instagram profile

Our community in Telegram

For each client individually, we draw up instructions according to his indicators and requests

Monthly rate:

How to get discounts

Other articles on the topic:

Contact us: